1. Home
  2. MIND vs BOLD Comparison

MIND vs BOLD Comparison

Compare MIND & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MIND Technology Inc. (DE)

MIND

MIND Technology Inc. (DE)

HOLD

Current Price

$5.61

Market Cap

48.2M

Sector

Industrials

ML Signal

HOLD

Logo Boundless Bio Inc.

BOLD

Boundless Bio Inc.

HOLD

Current Price

$2.59

Market Cap

57.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIND
BOLD
Founded
1987
2018
Country
United States
United States
Employees
157
N/A
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
48.2M
57.5M
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
MIND
BOLD
Price
$5.61
$2.59
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$4.00
AVG Volume (30 Days)
79.4K
262.6K
Earning Date
04-15-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
32.47
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$23.31
N/A
Revenue Next Year
$1.01
N/A
P/E Ratio
$22.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.66
$0.96
52 Week High
$14.50
$2.79

Technical Indicators

Market Signals
Indicator
MIND
BOLD
Relative Strength Index (RSI) 54.36 72.57
Support Level $4.83 $2.35
Resistance Level $6.89 $2.79
Average True Range (ATR) 0.33 0.10
MACD 0.10 -0.03
Stochastic Oscillator 71.80 84.21

Price Performance

Historical Comparison
MIND
BOLD

About MIND MIND Technology Inc. (DE)

MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in single segment namely, Seamap which provides services and products, including engineering, repairs and software licensing, utilized in marine exploration, marine survey and maritime security for marine survey companies, seismic survey contractors, research institutes, non-military government organizations and operators of port facilities and other offshore installations. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.

About BOLD Boundless Bio Inc.

Boundless Bio Inc is a clinical-stage oncology company. It is focused on developing cancer therapeutics that address the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Using its proprietary Spyglass platform, the company identifies targets essential for ecDNA functionality, then designs and develops small-molecule drugs called ecDNA-directed therapies (ecDTx) to inhibit those targets. Its main ecDTx candidate under development, BBI-940, is a novel, oral, selective degrader that has demonstrated potent anti-tumor activity across a range of cancer cell lines and mouse xenograft models, including single-agent tumor regressions.

Share on Social Networks: